ICP-248

· Beijing InnoCare Pharma Tech Co., Ltd.

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for ICP-248, covering 2025-06-19 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: ICP-248 in Combination With Azacitidine for the Treatment in Patients With Myeloid Malignancies [Phase 1]